Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept-Based Corticosteroid-Free Regimens in Renal Transplant
NCT00455013Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2007
- Primary completion
- Oct 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of belatacept in kidney transplant rejection, sponsored by Bristol Myers Squibb. Started Jul 2007; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00455013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455013.